Your browser doesn't support javascript.
loading
Clinical perspectives into the use of thalidomide for central nervous system tuberculosis.
Keddie, S; Bharambe, V; Jayakumar, A; Shah, A; Sanchez, V; Adams, A; Gnanapavan, S.
Affiliation
  • Keddie S; Emergency Care and Acute Medicine Clinical Academic Group, Neuroscience, The Royal London Hospital, Barts Health NHS Trust, London.
  • Bharambe V; National Hospital for Neurology and Neurosurgery, MRC Centre for Neuromuscular Diseases and Department of Molecular Neuroscience, University College London Hospitals NHS Foundation Trust, London.
  • Jayakumar A; The Walton Centre NHS Foundation Trust, Liverpool.
  • Shah A; Division of Infection, The Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Sanchez V; Emergency Care and Acute Medicine Clinical Academic Group, Neuroscience, The Royal London Hospital, Barts Health NHS Trust, London.
  • Adams A; Emergency Care and Acute Medicine Clinical Academic Group, Neuroscience, The Royal London Hospital, Barts Health NHS Trust, London.
  • Gnanapavan S; Emergency Care and Acute Medicine Clinical Academic Group, Neuroscience, The Royal London Hospital, Barts Health NHS Trust, London.
Eur J Neurol ; 25(11): 1345-1351, 2018 11.
Article in En | MEDLINE | ID: mdl-29935038

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Tuberculosis, Central Nervous System / Immunosuppressive Agents Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2018 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Tuberculosis, Central Nervous System / Immunosuppressive Agents Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2018 Document type: Article Country of publication: United kingdom